|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||||||||
| Investments: | |||||||||||||||
| Fixed maturity securities available for sale, at fair value, net of allowance for credit losses of $71 in 2026 and $104 in 2025 (amortized cost: $55,206 in 2026 and $55,292 in 2025) | |||||||||||||||
| Fixed maturity securities, at fair value under fair value option (related to investments held by consolidated variable interest entities (“VIEs”)) | |||||||||||||||
| Equity securities, at fair value | |||||||||||||||
| Preferred Stock | |||||||||||||||
| Equity securities | |||||||||||||||
| Derivative investments | |||||||||||||||
| Mortgage loans, net of allowance for credit losses of $108 in 2026 and $86 in 2025 | |||||||||||||||
| Investments in unconsolidated affiliates (2026 and 2025 include $277 and $262 related to investments held by consolidated VIEs and 2026 and 2025 include certain investments at fair value of $267 and $270) | |||||||||||||||
| Other long-term investments (2026 and 2025 include $264 and $248 related to investments held by consolidated VIEs) | |||||||||||||||
| Policy loans | |||||||||||||||
| Short-term investments (2026 and 2025 include $34 and $116 related to investments held by consolidated VIEs) | |||||||||||||||
| Total investments | |||||||||||||||
| Cash and cash equivalents (2026 and 2025 include $0 and $2 related to investments held by consolidated VIEs) | |||||||||||||||
| Reinsurance recoverable, net of allowance for credit losses of $19 in 2026 and $18 in 2025 | |||||||||||||||
| Goodwill | |||||||||||||||
| Prepaid expenses and other assets (certain assets held at fair value of $0 in 2026 and $24 in 2025) | |||||||||||||||
| Other intangible assets, net | |||||||||||||||
| Market risk benefits asset | |||||||||||||||
| Income taxes receivable | |||||||||||||||
| Deferred tax asset, net | |||||||||||||||
| Total assets | |||||||||||||||
| LIABILITIES AND EQUITY | |||||||||||||||
| Liabilities: | |||||||||||||||
| Contractholder funds | |||||||||||||||
| Future policy benefits | |||||||||||||||
| Market risk benefits liability | |||||||||||||||
| Accounts payable and accrued liabilities | |||||||||||||||
| Income taxes payable | |||||||||||||||
| Notes payable | |||||||||||||||
| Funds withheld for reinsurance liabilities | |||||||||||||||
| Lease liabilities | |||||||||||||||
| Total liabilities | |||||||||||||||
| Equity: | |||||||||||||||
| Preferred stock $0.001 par value; 2026 and 2025 shares authorized 25,000,000: outstanding and issued 5,000,000 | |||||||||||||||
| Common stock, $0.001 par value; 2026 and 2025 shares authorized 500,000,000; outstanding of 130,940,695 and 135,610,292; and issued of 137,004,894 and 137,056,106 | |||||||||||||||
| Additional paid-in-capital | |||||||||||||||
| Retained earnings | |||||||||||||||
| Accumulated other comprehensive income (loss) ("AOCI") | |||||||||||||||
| Treasury stock, at cost (6,064,199 shares and 1,445,814 shares as of June 30, 2026 and December 31, 2025, respectively) | |||||||||||||||
| Total F&G Annuities & Life, Inc. shareholders' equity | |||||||||||||||
| Non-controlling interests | |||||||||||||||
| Total equity | |||||||||||||||
| Total liabilities and equity | |||||||||||||||
Loading...
